The U.S. Food and Drug Administration (FDA) is under fire for its management of drug approvals for patients with rare diseases, such as those affected by primary mitochondrial myopathy. This
Category: Meds
Pharmacists Have a Vital Function in Expanding Medicaid Access to Digital TherapeuticsPharmacists Have a Vital Function in Expanding Medicaid Access to Digital Therapeutics
More than 78 million Americans rely on Medicaid or CHIP for their medical care. However, many of these individuals cannot access FDA-approved digital therapeutics because their state Medicaid programs do
Voicemail Systems and Diagnostic Codes Endanger Patient Medication AvailabilityVoicemail Systems and Diagnostic Codes Endanger Patient Medication Availability
I Will No Longer Patronize CVS Pharmacies: Here’s My Reason Dr. Arthur Lazarus, an experienced physician and former Doximity Fellow, has publicly announced his choice to stop using CVS pharmacies
Medicine Repositioning for Improved Pain Control and Sleep Disorder TherapyMedicine Repositioning for Improved Pain Control and Sleep Disorder Therapy
In the current dynamic healthcare environment, the transition towards value-based care calls for creative, economical, and patient-focused methodologies. An important yet underexploited tactic is drug repurposing, which entails identifying new
Reassessing the U.S. Drug Classification Framework: A Transition from Prejudice to ResearchReassessing the U.S. Drug Classification Framework: A Transition from Prejudice to Research
In 1971, President Nixon launched a conflict that would transform the United States: The War on Drugs. As a crucial component of that initiative, he implemented the Controlled Substances Act